Valuation : Evogene Ltd.

Market Cap 76.71L 0 66L 62.1L 56.73L 1.06Cr 72Cr 1.06Cr 7.34Cr 2.85Cr 37Cr 2.88Cr 2.82Cr 119.7Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 76.71L 0 66L 62.1L 56.73L 1.06Cr 72Cr 1.06Cr 7.34Cr 2.85Cr 37Cr 2.88Cr 2.82Cr 119.7Cr EV / Sales 2026 *
5.17x
EV / Sales 2027 * 2.95x
Free-Float
72.14%
Yield 2026 *
-
Yield 2027 * -
1 day+3.58%
1 week+6.43%
Current month+2.65%
1 month-0.35%
3 months+6.16%
6 months-34.00%
Current year-43.25%
1 week 159.2
Extreme 159.2
173.1
1 month 158
Extreme 158
229.8
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
478.7
3 years 115.1
Extreme 115.1
3,700
5 years 115.1
Extreme 115.1
10,180
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 01/12/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/01/2022
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 03/06/2010
Chairman 60 01/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
11/08/26 Buy

Director

4,60,000 2.9111%
04/08/26 Buy

Director

8,00,000 5.0628%
01/04/26 Other

Executive/Senior Manager

20,000 0.2294%
Change 5-day change 1-year change 3-year change Capi.($)
+3.58%+6.43%-59.09%-93.96% 76.71L
-2.54%-2.84%-1.90%+14.52% 4.89TCr
-0.40%+1.03%+439.20%+499.20% 4.5TCr
-1.42%+2.30%+45.46%+19.36% 4.41TCr
-1.22%-2.31%+12.40%+71.48% 4.07TCr
+0.53%-1.36%+16.04%+48.23% 3.35TCr
-0.21%+9.14% - - 1.78TCr
-0.35%-1.56%+22.59%+116.19% 1.65TCr
-1.01%+0.50%+15.83%+27.98% 1.47TCr
-1.65%-1.03%+77.75%+37.63% 1.38TCr
Average -0.47%+1.12%+63.14%+82.29% 2.75TCr
Weighted average by Cap. -1.03%+0.11%+94.86%+122.11%

Financials

2026 *2027 *
Net sales 14.84L 0 12.77L 12.01L 10.98L 20.53L 14Cr 20.59L 1.42Cr 55.09L 7.19Cr 55.73L 54.51L 23Cr 26L 0 22.37L 21.05L 19.23L 35.97L 25Cr 36.07L 2.49Cr 96.52L 13Cr 97.63L 95.5L 41Cr
Net income -1.67Cr -0 -1.44Cr -1.35Cr -1.23Cr -2.31Cr -157.55Cr -2.31Cr -16Cr -6.19Cr -81Cr -6.27Cr -6.13Cr -260.41Cr -1.39Cr -0 -1.2Cr -1.13Cr -1.03Cr -1.93Cr -131.38Cr -1.93Cr -13Cr -5.17Cr -67Cr -5.23Cr -5.11Cr -217.15Cr
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
38
Date Price Change Volume
04/26/04 ILA 170.60 +3.58% 49,286
03/26/03 ILA 164.70 +1.23% 26,775
02/26/02 ILA 162.70 +0.62% 20,098
01/26/01 ILA 161.70 -2.71% 62,621
31/26/31 ILA 166.20 +3.68% 31,324

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock